Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604745 · ClinicalTrials.gov registry record
Degenerative Mitral Regurgitation in Intermediate Risk Patients
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 13
- Enrollment target
NCT02604745 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 13 participants.
The verdict
NCT02604745 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The main objective of this project is to determine intermediate-term echocardiographic outcomes in Medicare eligible patients (65 years of age and older) with moderate surgical risk who have undergone mitral valve surgery for degenerative mitral regurgitation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02604745
The ClinicalTrials.gov registry entry for NCT02604745 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02604745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02604745 about?
NCT02604745 is a clinical study titled "Degenerative Mitral Regurgitation in Intermediate Risk Patients". The main objective of this project is to determine intermediate-term echocardiographic outcomes in Medicare eligible patients (65 years of age and older) with moderate surgical risk who have undergone mitral valve surgery for degenerative mitral regurgitation.
What is the current status of trial NCT02604745?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2016-03. Estimated completion is 2021-01.
Who is sponsoring clinical trial NCT02604745?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.